Neuralsync: The Singapore AI Startup Finally Cracking Workplace Productivity

In a converted shophouse along Mohamed Sultan Road, a team of 40 engineers and neuroscientists are quietly building what could become Singapore's next unicorn. Neuralsync, founded in 2021, has just closed a Series B funding round that values the company at $95 million—a milestone that reflects growing investor appetite for Singapore's brain-computer interface sector, which has attracted over $340 million in regional funding since 2024.

The company's core product is deceptively simple: a non-invasive headset that monitors neural patterns to detect cognitive fatigue, distraction, and stress in real-time. Enterprise clients—including three of Singapore's top five banks and two multinational tech firms headquartered in Jurong—use the platform to optimize team performance and reduce burnout-related attrition. Neuralsync claims its dashboard has helped participating organisations reduce sick leave by an average of 23 percent over two years.

What sets Neuralsync apart in a crowded field is its regulatory pragmatism. While competitors chase approvals from the FDA or EU regulators, Neuralsync secured Health Sciences Authority approval in Singapore in March 2025 and has since expanded to Malaysia and Vietnam. The company's chief scientific officer previously led neuroimaging research at the A*STAR's Neuroscience and Behavioural Disorders programme—lending credibility that private startups often lack.

The $18 million Series B, led by Vertex Growth Partners with participation from existing backers Sequoia Southeast Asia and Singapore's Wavemaker Partners, arrives at an inflection point. Neuralsync is now competing directly with international players that have deeper pockets but less understanding of Asia's regulatory landscape and workplace cultures. The company plans to hire 60 more people—mostly based at its Ubi Avenue 1 headquarters, though it's opening a Kuala Lumpur office next quarter.

Industry observers note the timing matters. As corporations across Southeast Asia grapple with hybrid work adoption and talent retention, demand for tools that provide objective data on employee wellbeing has surged. Neuralsync's pricing—around SGD 8,000 per employee annually for enterprise contracts—remains steep, but early adopters argue the ROI justifies the cost.

The broader significance: Singapore's innovation ecosystem is maturing beyond fintech and e-commerce clones. Neuralsync represents a new wave of deep-tech startups that combine scientific rigour, regulatory savvy, and regional ambition. For a city-state betting heavily on becoming a research and development hub, that shift deserves attention.

This article was compiled by AI from the sources linked above and screened before publishing. See our editorial standards.